Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    October 2022
  1. CAMILLERI M, Dilmaghani S
    Treatment of Irritable Bowel Syndrome Using Fecal Microbiota Transplantation: A Step Forward?
    Gastroenterology. 2022;163:815-817.
    PubMed    


    September 2022
  2. KESZTHELYI D
    Histamine-producing bacteria: the missing link in irritable bowel syndrome?
    Gastroenterology. 2022 Sep 8. pii: S0016-5085(22)01038.
    PubMed    


    August 2022
  3. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed     Abstract available


    July 2022
  4. LEMBO A, Sultan S, Chang L, Heidelbaugh JJ, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Gastroenterology. 2022;163:137-151.
    PubMed     Abstract available


  5. CHANG L, Sultan S, Lembo A, Verne GN, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Gastroenterology. 2022;163:118-136.
    PubMed     Abstract available


    June 2022
  6. ZIA JK, Lenhart A, Yang PL, Heitkemper MM, et al
    Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review.
    Gastroenterology. 2022 Jun 15. pii: S0016-5085(22)00646.
    PubMed     Abstract available


  7. EL-SALHY M, Winkel R, Casen C, Hausken T, et al
    Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00625.
    PubMed     Abstract available


    April 2022
  8. BUSHYHEAD D, Quigley EMM
    Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management.
    Gastroenterology. 2022 Apr 7. pii: S0016-5085(22)00357.
    PubMed     Abstract available


  9. AHUJA A
    Minority Patients With Irritable Bowel Syndrome Receive More Gastroenterology-Related Procedures Than White Counterparts: Nuances in Disparities Research.
    Gastroenterology. 2022;162:1354-1355.
    PubMed    


    March 2022
  10. CHEY WD, Hashash JG, Manning L, Chang L, et al
    AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
    Gastroenterology. 2022 Mar 22. pii: S0016-5085(21)04084.
    PubMed     Abstract available


    February 2022
  11. GAO J, Xiong T, Grabauskas G, Owyang C, et al
    Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell-prostaglandin E2.
    Gastroenterology. 2022 Feb 12. pii: S0016-5085(22)00144.
    PubMed     Abstract available


    January 2022
  12. BLACK CJ, Ford AC
    Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome.
    Gastroenterology. 2022 Jan 22. pii: S0016-5085(22)00037.
    PubMed    


    December 2021
  13. DEB B, Sharma M, Fletcher JG, Srinivasan SG, et al
    Inadequate Rectal Pressure and Insufficient Relaxation and Abdominopelvic Coordination in Defecatory Disorders.
    Gastroenterology. 2021 Dec 21. pii: S0016-5085(21)04093.
    PubMed     Abstract available


  14. MAGNUS Y, BouSaba J, Sannaa W, McKinzie S, et al
    Bile Acid Diarrhea Is Associated with Increased Intestinal Permeability Compared to Irritable Bowel Syndrome-Diarrhea.
    Gastroenterology. 2021 Dec 16. pii: S0016-5085(21)04078.
    PubMed    


    November 2021
  15. ZHENG T, Camargo-Tavares L, Bonfiglio F, Marques FZ, et al
    Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank.
    Gastroenterology. 2021;161:1712-1714.
    PubMed    


    October 2021
  16. CHANG L
    How to Approach a Patient with Difficult-to-Treat IBS.
    Gastroenterology. 2021;161:1092-1098.
    PubMed    


    September 2021
  17. KEEFER L, Ballou SK, Drossman DA, Ringstrom G, et al
    A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03494.
    PubMed     Abstract available


  18. CAMILLERI M
    New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.
    Gastroenterology. 2021;161:761-764.
    PubMed    


    July 2021
  19. MIHINDUKULASURIYA KA, Mars RAT, Johnson AJ, Ward T, et al
    Multi-omics analyses show disease, diet, and transcriptome interactions with the virome.
    Gastroenterology. 2021 Jul 7. pii: S0016-5085(21)03234.
    PubMed     Abstract available


    June 2021
  20. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    


  21. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available


    April 2021
  22. KHOSHBIN K, Khanna L, Maselli D, Atieh J, et al
    Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00642.
    PubMed     Abstract available


    March 2021
  23. HASAN SS, Whorwell PJ, Miller V, Morris J, et al
    Six versus twelve sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00463.
    PubMed    


    February 2021
  24. MAHURKAR-JOSHI S, Rankin CR, Videlock EJ, Soroosh A, et al
    The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p and MicroRNA-338-3p, are Downregulated in Irritable Bowel Syndrome and are Associated with Barrier Function and MAPK signaling.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00430.
    PubMed     Abstract available


    January 2021
  25. MARGOLIS KG, Cryan JF, Mayer EA
    The Microbiota-Gut-Brain Axis: From Motility to Mood.
    Gastroenterology. 2021 Jan 22. pii: S0016-5085(21)00268.
    PubMed     Abstract available


  26. MARS RAT, Frith M, Kashyap PC
    Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?
    Gastroenterology. 2021;160:538-555.
    PubMed     Abstract available


  27. O'TOOLE PW, Shanahan F
    Transplanting Microbes for Irritable Bowels or Irritated Microbes or Both?
    Gastroenterology. 2021;160:15-17.
    PubMed    


    October 2020
  28. CHEY WD, Keefer L, Whelan K, Gibson PR, et al
    Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35281.
    PubMed     Abstract available


    September 2020
  29. MA C, Congly SE, Novak KL, Belletrutti PJ, et al
    Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35224.
    PubMed     Abstract available


  30. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available


    July 2020
  31. HOLVOET T, Joossens M, Vazquez-Castellanos JF, Christiaens E, et al
    Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34937.
    PubMed     Abstract available


  32. QUIGLEY EM, Murray JA, Pimentel M
    AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.
    Gastroenterology. 2020 Jul 14. pii: S0016-5085(20)34928.
    PubMed     Abstract available


  33. WEERTS ZZRM, Masclee AAM, Jonkers DMAE, Keszthelyi D, et al
    Reply.
    Gastroenterology. 2020;159:396-397.
    PubMed    


  34. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    


  35. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    


    April 2020
  36. SPERBER AD, Bangdiwala SI, Drossman DA, Ghoshal UC, et al
    Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.
    Gastroenterology. 2020 Apr 12. pii: S0016-5085(20)30487.
    PubMed     Abstract available


  37. BLACK CJ, Moayyedi P, Quigley EM, Ford AC, et al
    Peppermint Oil in Irritable Bowel Syndrome.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30478.
    PubMed    


  38. ZHOU Q, Verne GN
    Are the Rome Criteria a Sound Standard for Gastrointestinal Disorders Worldwide?
    Gastroenterology. 2020;158:1212-1214.
    PubMed    


    February 2020
  39. GRABAUSKAS G, Wu X, Gao J, Li JY, et al
    Prostaglandin E2, Produced by Mast Cells in Colon Tissues from Patients with Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice.
    Gastroenterology. 2020 Feb 18. pii: S0016-5085(20)30232.
    PubMed     Abstract available


  40. BLACK CJ, Ford AC
    Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30227.
    PubMed     Abstract available


    January 2020
  41. PALSSON OS, Whitehead W, Tornblom H, Sperber AD, et al
    Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Gastroenterology. 2020 Jan 6. pii: S0016-5085(20)30001.
    PubMed     Abstract available


    December 2019
  42. DELSHAD SD, Almario CV, Chey WD, Spiegel BMR, et al
    Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Gastroenterology. 2019 Dec 18. pii: S0016-5085(19)41941.
    PubMed     Abstract available


  43. JEFFERY IB, Das A, O'Herlihy E, Coughlan S, et al
    Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Gastroenterology. 2019 Dec 13. pii: S0016-5085(19)41920.
    PubMed     Abstract available


    November 2019
  44. CASH BD
    A Minty Breath of Fresh Air for Irritable Bowel Syndrome.
    Gastroenterology. 2019 Nov 12. pii: S0016-5085(19)41534.
    PubMed    


  45. KAMPHUIS JBJ, Guiard B, Leveque M, Olier M, et al
    Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41528.
    PubMed     Abstract available


  46. RANGAN V, Ballou S, Shin A, Camilleri M, et al
    Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction, Based on IBS in America Survey.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41527.
    PubMed    


    October 2019
  47. SHAPIRO J, El-Serag HB, Chan J
    DURABILITY AND EFFECTIVENESS OF COGNITIVE BEHAVIORAL THERAPY FOR IRRITABLE BOWEL SYNDROME.
    Gastroenterology. 2019 Oct 12. pii: S0016-5085(19)41447.
    PubMed    


    September 2019
  48. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: